Deborah Moreno-Alonso, Beatriz García García, Clara Madrid-Alejos, Georgina Morón-Cazalilla, Sílvia Llorens-Torromé, Iris Crespo, Miguel Ángel Álvarez Juárez, María Argüello Marina, Marta Callejas Charavia, Ana Facal-Malvar, Daniel Gainza-Miranda, Cistina Monforte-Royo
{"title":"Bridging the Gap: An Updated Systematic Integrative Review of Palliative Care Integration in Hematological Malignancies.","authors":"Deborah Moreno-Alonso, Beatriz García García, Clara Madrid-Alejos, Georgina Morón-Cazalilla, Sílvia Llorens-Torromé, Iris Crespo, Miguel Ángel Álvarez Juárez, María Argüello Marina, Marta Callejas Charavia, Ana Facal-Malvar, Daniel Gainza-Miranda, Cistina Monforte-Royo","doi":"10.1016/j.soncn.2025.151962","DOIUrl":null,"url":null,"abstract":"<p><strong>Objectives: </strong>To update our previous systematic review by assessing gaps and changes in palliative care for patients with hematological malignancies ten years on, to identify emerging themes in palliative care delivery and to provide recommendations for enhancing palliative care integration within hematology services.</p><p><strong>Methods: </strong>We comprehensively searched PubMed, CINAHL, Cochrane, Scopus and Web of Science for articles published from 1 July 2015 to 30 December 2024, then extracted and synthesized the data using the integrative method described by Whittemore and Knafl. To enable us to focus on changes in practice and emerging trends over the 10 years elapsed since the period covered by our previous review, we excluded the 99 articles analyzed previously.</p><p><strong>Results: </strong>Of 1605 articles identified, 68 were included in our final analysis. We identified six themes: access and referral to palliative care; end-of-life care; symptom burden and clinical management; home care; emotional and psychological support; and miscellaneous aspects of palliative care. Patients with hematological malignancies have a similarly high or higher symptom burden as those with solid tumors, yet palliative care for hematological patients remains underutilized. Access barriers to palliative care for this high-risk population include misconceptions about the role of palliative care, lack of communication between palliative and hematological teams, clinician's own shortcomings with respect to their knowledge, experience and training, and institutional barriers. Where palliative care is used, consultations tend to happen when the patient is already in the late stages of disease.</p><p><strong>Conclusions: </strong>The evidence for the benefits of palliative care for hematological patients points overwhelmingly to improved symptom management and better emotional and psychological support for those nearing the end of life. Initiatives are needed to tackle the negative connotations of the term \"palliative\" so that patients may gain access to palliative care sooner. Gaps in clinicians' own knowledge and experience should be addressed through comprehensive training and awareness-raising programs to remove barriers to accessing palliative care.</p><p><strong>Implications for nursing practice: </strong>Nursing insights have highlighted the challenges of caring for patients with hematological malignancies within a healthcare system primarily focused on cure. As nursing professionals are uniquely positioned to bridge the gap between curative and palliative approaches, they carry out multidimensional assessments and prioritize interdisciplinary collaboration in patient care. Strengthening collaboration between nurses and hematology specialists could support improved long-term planning and timely access to palliative care for patients with hematological malignancies.</p>","PeriodicalId":54253,"journal":{"name":"Seminars in Oncology Nursing","volume":" ","pages":"151962"},"PeriodicalIF":2.3000,"publicationDate":"2025-08-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Seminars in Oncology Nursing","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1016/j.soncn.2025.151962","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"NURSING","Score":null,"Total":0}
引用次数: 0
Abstract
Objectives: To update our previous systematic review by assessing gaps and changes in palliative care for patients with hematological malignancies ten years on, to identify emerging themes in palliative care delivery and to provide recommendations for enhancing palliative care integration within hematology services.
Methods: We comprehensively searched PubMed, CINAHL, Cochrane, Scopus and Web of Science for articles published from 1 July 2015 to 30 December 2024, then extracted and synthesized the data using the integrative method described by Whittemore and Knafl. To enable us to focus on changes in practice and emerging trends over the 10 years elapsed since the period covered by our previous review, we excluded the 99 articles analyzed previously.
Results: Of 1605 articles identified, 68 were included in our final analysis. We identified six themes: access and referral to palliative care; end-of-life care; symptom burden and clinical management; home care; emotional and psychological support; and miscellaneous aspects of palliative care. Patients with hematological malignancies have a similarly high or higher symptom burden as those with solid tumors, yet palliative care for hematological patients remains underutilized. Access barriers to palliative care for this high-risk population include misconceptions about the role of palliative care, lack of communication between palliative and hematological teams, clinician's own shortcomings with respect to their knowledge, experience and training, and institutional barriers. Where palliative care is used, consultations tend to happen when the patient is already in the late stages of disease.
Conclusions: The evidence for the benefits of palliative care for hematological patients points overwhelmingly to improved symptom management and better emotional and psychological support for those nearing the end of life. Initiatives are needed to tackle the negative connotations of the term "palliative" so that patients may gain access to palliative care sooner. Gaps in clinicians' own knowledge and experience should be addressed through comprehensive training and awareness-raising programs to remove barriers to accessing palliative care.
Implications for nursing practice: Nursing insights have highlighted the challenges of caring for patients with hematological malignancies within a healthcare system primarily focused on cure. As nursing professionals are uniquely positioned to bridge the gap between curative and palliative approaches, they carry out multidimensional assessments and prioritize interdisciplinary collaboration in patient care. Strengthening collaboration between nurses and hematology specialists could support improved long-term planning and timely access to palliative care for patients with hematological malignancies.
目的:通过评估十年来血液恶性肿瘤患者姑息治疗的差距和变化来更新我们之前的系统综述,确定姑息治疗提供的新主题,并为加强血液服务中的姑息治疗整合提供建议。方法:综合检索PubMed、CINAHL、Cochrane、Scopus和Web of Science,检索2015年7月1日至2024年12月30日发表的论文,采用Whittemore和Knafl描述的整合方法对数据进行提取和综合。为了使我们能够关注自上次审查所涵盖的时期以来10年来实践中的变化和新趋势,我们排除了之前分析的99篇文章。结果:在鉴定的1605篇文章中,有68篇纳入我们的最终分析。我们确定了六个主题:获取和转诊到姑息治疗;临终关怀;症状负担及临床处理;家庭护理;情感和心理支持;以及缓和医疗的其他方面。血液系统恶性肿瘤患者与实体肿瘤患者具有相似的高或更高的症状负担,但血液系统患者的姑息治疗仍未得到充分利用。这一高危人群获得姑息治疗的障碍包括对姑息治疗作用的误解、姑息治疗和血液团队之间缺乏沟通、临床医生自身在知识、经验和培训方面的不足以及体制障碍。在使用姑息治疗的地方,会诊往往是在病人已经处于疾病晚期时进行的。结论:姑息治疗对血液病患者的益处的证据压倒性地指向改善症状管理和对那些接近生命终点的人更好的情感和心理支持。需要采取行动解决“姑息治疗”一词的负面含义,以便患者能够更快地获得姑息治疗。应通过全面的培训和提高认识规划来解决临床医生自身知识和经验方面的差距,以消除获得姑息治疗的障碍。对护理实践的影响:护理见解强调了在医疗保健系统中主要关注治疗的血液系统恶性肿瘤患者的护理挑战。由于护理专业人员在弥合治疗和姑息治疗方法之间的差距方面处于独特的地位,他们在患者护理中进行多维评估并优先考虑跨学科合作。加强护士和血液学专家之间的合作可以支持改善长期规划,及时获得恶性血液学患者的姑息治疗。
期刊介绍:
Seminars in Oncology Nursing is a unique international journal published six times a year. Each issue offers a multi-faceted overview of a single cancer topic from a selection of expert review articles and disseminates oncology nursing research relevant to patient care, nursing education, management, and policy development.